Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Issued capital [member] Stock Option Reserve [Member] Treasury Stock [Member] Accumulated Other Comprehensive Income Loss [Member] Retained earnings [member] Equity attributable to owners of parent [member] Non-controlling interests [member] Classes of intangible assets and goodwill [axis] iOx IPR&D [Member] Tarus IPR&D [Member] Stimunity [Member] Saugatuck [Member] Subsidiaries [axis] IOX [Member] Consolidated structured entities [axis] Salva Rx [Member] Range [axis] Bottom of range [member] Top of range [member] Geographical areas [axis] Country Of British Virgin Islands [Member] Delaware [Member] Categories of related parties [axis] Subsidiaries Two [Member] Types of antidilutive instruments [axis] Warrants [member] Stock Options [Member] Restricted Stock Units [Member] Classes of financial instruments [axis] U S D C [Member] Usdt [Member] Total [Member] Intangible assets material to entity [axis] T O N [Member] B I T C O I N [Member] U S D 1 [Member] Locked Ton [Member] Classes of property, plant and equipment [axis] G P Us [Member] G P U Deposits [Member] Right Of Use Asset [Member] Classes of share capital [axis] Class B Warrants [Member] Class C Warrants [Member] Placement Agent Warrants [Member] Seies B Warrants [Member] Seies C Warrants [Member] Placement Agent Warrants 2026 [Member] Series B Warrants [Member] Series C Warrants [Member] Placement Agents Warrants [Member] Ton Token Volatility [Member] Counterparties [axis] ATM [Member] Series A Warrants And Pre Funded Warrants [Member] Restricted share units [member] Measurement [axis] Vested Stock Option [Member] Defined benefit plans [axis] PBI 2021 Equity Incentive Plan [Member] Stock Option Granted [Member] Interest rate benchmarks [axis] January 132021 [Member] January 192022 [Member] February 152022 [Member] June 82022 [Member] July 272022 [Member] March 302023 [Member] March 72025 [Member] July 272026 [Member] March 112026 [Member] C R O [Member] C R O Agreement [Member] Michael Terpin [Member] Associates [axis] Director Compensation [Member] F Daniel Siciliano [Member] Gregory H Bailey M D [Member] James Mellon [Member] Steven Mintz [Member] Jean Christophe Renondin M D [Member] Justin Stebbing M D Ph D [Member] Linda Kozick [Member] Mark Simon [Member] Robert Glassman [Member] Executive Officer Compensation [Member] Brittany Kaiser [Member] Enzo Villani [Member] Wes Levitt [Member] Yury Mitin [Member] Alexander Pickett [Member] Ian Walters [Member] Andrea Park [Member] Allan Shaw [Member] Robert Kramer [Member] Brian Wiley [Member] Justin Fairchild [Member] Alexander Pickett Two [Member] Ian B Walters [Member] Ian B Walters Two [Member] Ian B Walters Three [Member] Andrea E Park [Member] Andrea E Park Two [Member] Allan Shaw Two [Member] Allan Shaw Three [Member] Robert Kramer Two [Member] Robert Kramer Three [Member] Brian Wiley Two [Member] Levels of fair value hierarchy [axis] Amortized Cost [Member] Fair Value To Other Comprehensive Income [Member] Fair Value Through Profit Or Loss [Member] Impairment of financial assets [axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Digital Compute [Member] Immuno Oncology [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of financial position [abstract] Assets Current assets Cash and cash equivalents Restricted cash Accounts receivable Stablecoin Digital assets at fair value, TON, current Prepaid expenses and other receivables Total current assets Non-current assets Digital assets at fair value, TON, net of current portion Right-of-use asset Property, plant, and equipment, net Equipment deposits Other assets Total non-current assets Total assets Liabilities and Equity Current liabilities Accounts payable and accrued liabilities TON payable to settle put rights exercised Lease liability - current Put right liability Total current liabilities Non-current liabilities Lease liability - non-current Warrant liability Total non-current liabilities Total liabilities Commitments and Contingent Liabilities (Note 20) Shareholders’ Equity Capital stock Stock option reserve Accumulated deficit Treasury stock Total equity attributable to owners of the Company Non-controlling interest Total equity Total liabilities and equity Profit or loss [abstract] Revenues Expenses Research and development General and administrative expenses Depreciation and amortization expense Loss from operations Change in fair value of warrant liability Change in fair value of deferred purchase price payable - Tarus and deferred obligation - iOx milestone Change in fair value of put rights, net of redemptions Loss on revaluation of digital assets Loss on revaluation of digital asset receivables Realized loss on sale of digital assets Realized loss on novation of digital assets to investor Gain on settlement with Parexel - iOx CRO Loss on Registered Direct Offering Offering costs Impairment loss - iOx IPR&D Impairment loss - Tarus IPR&D Impairment loss - Stimunity Impairment loss - Saugatuck Commitment fee under Committed Purchase Agreement Gain on dissolution of investment in associate Gain from sale of investment in public company Impairment loss - investment in Compedica Loss on revaluation of investment in Compedica Change in fair value of TON payable to settle put rights exercised Gain on settlement of TON payable Loss on settlement of put right liability Foreign exchange transaction (loss) gain Interest (expense) income, net Gain on extinguishment of debt Share of losses from equity method investment Loss before benefit for income taxes Income tax benefit Net loss Other comprehensive loss Net unrealized loss on investments Total comprehensive loss for period Net loss attributable to: Owners of the Company Non-controlling interest Comprehensive loss attributable to: Owners of the Company Non-controlling interest Loss per share Loss per share, Basic Loss per share, Diluted Weighted average shares outstanding Weighted average shares outstanding, Basic Weighted average shares outstanding, Diluted Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance, value Begnning balance, shares Balance, April 1, 2022 (Pre-Split), shares Share-based compensation expense Shares issued under Registered Direct Offering Shares issued under Registered Direct Offering, shares Shares issued related to the ATM agreement, net of share issuance costs Shares issued related to the ATM agreement, net of share issuance costs , shares Shares issued or accrued for services Shares issued or accrued for services, shares Shares issued pursuant to distribution of restricted stock units Shares issued pursuant to distribution of restricted stock units, shares Derecognition of investment in public company Net loss for the year Correction of prior period overstated share-based compensation expense Shares issued under private placement, net of share issuance costs Shares issued under private placement, net of share issuance costs, shares Pre-Funded warrants exercised Pre-Funded warrants exercised, shares Additional round up shares issued for fractional shares in connection with 1-for-20 reverse share split Additional round up shares issued for fractional shares in connection with 1-for-20 reverse stock split, shares Shares issued for accrued bonuses Shares issued accrued for bonuses, shares Shares issued under private placement, net of share issuance costs and put rights Shares issued under private placement, net of share issuance costs and put rights , shares Shares issued relating to the acquisition of Compedica Shares issued relating to the acquisition of Compedica, shares Shares issued under registered direct offering, net of share issuance costs Shares issued under registered direct offering, net of share issuance costs , shares Exercise of pre-funded warrants Exercise of pre-funded warrants , shares Treasury stock obtained in exchange for return of investment interest to Compedica Treasury stock obtained in exchange for return of investment interest to Compedica , shares Put rights exercised and return of shares Put rights exercised and return, shares Ending balance, value Ending Balance, shares Disclosure of reconciliation of changes in intangible assets and goodwill [table] Cash flows from operating activities: Net loss for the period Adjustments for non-cash items: Share-based compensation expense Change in fair value of deferred purchase price payable - Tarus and deferred obligation - iOx milestone Loss on Registered Direct Offering Offering costs Impairment loss Commitment fee under Committed Purchase Agreement Gain on dissolution of investment in associate Gain from sale of investment in public company Decrease in deferred tax liability Unrealized loss on change in fair value of digital assets Unrealized loss on change in fair value of digital asset receivables Realized loss on sale of digital assets Realized loss on novation of digital asset receivables Loss on impairment - investment in Compedica Loss on remeasurement of investment in Compedica Change in fair value of warrant liability Change in fair value of put rights, net of redemptions Loss from equity method investment Change in fair value of TON payable to settle put rights exercised Gain on settlement of TON payable Loss on exercise of put right liability Loss on extinguishment of debt Noncash interest expense Gain on settlement with Parexel - iOx CRO Expenses settled using stablecoin Revenues received in TON tokens Share of loss in associate Fair value of shares issued for services Depreciation and amortization Changes in operating working capital: Accounts receivable Prepaid expenses and other receivables Other assets Accounts payable and accrued liabilities Other current liabilities Net cash used in operating activities Cash flows from investing activities: Proceeds from sale of investment in public company Purchases of stablecoin Purchases of digital assets Sales of stablecoin Sales of digital assets Purchases of fixed assets Equipment deposits Cash paid for investment in Compedica Net cash (used in) provided by investing activities Cash flows from financing activities: Proceeds from exercise of Pre-Funded Warrants Proceeds from shares issued under private placement Proceeds from Registered Direct Offering Proceeds from shares issued under ATM and Committed Purchase Agreement Share issuance costs Put right issuance costs Repayment of lease liability Payments on external debt Deferred financing costs Loan termination fee Shares from RSU distribution Net cash provided by financing activities Decrease in cash, cash equivalents, restricted during period Cash and cash equivalents at beginning of period Cash, cash equivalents, and restricted cash at end of period Supplemental disclosure of cash flow information: Cash paid for interest Supplemental disclosure of non-cash investing and financing activities: Exchange of Stimunity Convertible Note for Stimunity shares at fair value Capital expenditures included in accounts payable Right-of-use asset acquired Lease liability incurred Contribution of digital assets Contribution of stablecoin Contribution of digital assets receivable Contribution of stablecoin receivable Value of shares used to purchase interest in Compedica Treasury stock obtained in exchange for return of investment interest to Compedica Put rights issued to investors Share issuance costs settled in Company stock Share issuance costs settled in warrants on the Company's stock Settlement of put right liability using stablecoin receivable Exercise of put rights Settlement of put right liability using digital asset receivables Receipt of digital assets receivable, TON tokens Stablecoin used to purchase digital assets Sale of digital assets settled in stablecoin Exchange of Bitcoin for TON tokens External debt proceeds received in stablecoin Payments on external debt using digital assets Non-cash operating activities: Prepaid expenses obtained in exchange for stablecoin Nature Of Operations NATURE OF OPERATIONS Notes and other explanatory information [abstract] GOING CONCERN BASIS OF PRESENTATION Significant Accounting Policies SIGNIFICANT ACCOUNTING POLICIES PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS Stablecoin STABLECOIN Digital Assets DIGITAL ASSETS Property Plant And Equipment And Right-of-use Assets PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS INVESTMENT IN COMPEDICA Warrant Liability WARRANT LIABILITY Put Right Liability And Ton Payable PUT RIGHT LIABILITY AND TON PAYABLE Accounts Payable And Accrued Liabilities ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Lease Liability LEASE LIABILITY Bitgo Prime Loan BITGO PRIME LOAN INCOME TAXES Capital Stock And Reserves CAPITAL STOCK AND RESERVES STOCK OPTION RESERVE LOSS PER SHARE COMMITMENTS AND CONTINGENT LIABILITIES RELATED PARTY TRANSACTIONS Financial Instruments And Risk Management FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Segment Reporting SEGMENT REPORTING Capital Management CAPITAL MANAGEMENT NON-CONTROLLING INTEREST SUBSEQUENT EVENTS Financial Instruments Impairment of Financial Assets and Intangible Assets Cash, Cash Equivalents, and Restricted Cash Impairment of Property, Plant, and Equipment and Indefinite Life Intangible Assets other than Goodwill Share-based Payments Loss Per Share Investment in Public Company Investment in Associate Research and Development Expenses Contingent Liability Determination of Fair Value Income Tax Stablecoin Digital Assets Revenue from Contracts with Customers Accounts Receivable Expected Credit Losses Property, Plant, and Equipment Recent Accounting Pronouncements Schedule of anti-dilutive effect on loss per share Schedule of prepaid expenses and other receivables Schedule of stablecoin Schedule of stablecoin purchases Schedule of Digital assets Schedule of digital assets purchases [custom:SeheduleOfTonTokensTableTextBlock] Schedule of movements in Receivables – digital assets Schedule of property, plant, and equipment, equipment deposits, and right-of-use assets Schedule of investment balance Schedule of changes in the warrant liability Schedule of inputs associated with calculating the fair value Schedule of fair value Schedule of Placement agent warrants Schedule of 2026 placement agent warrants Schedule of put right liability Schedule of put right liability Schedule of TON payable Schedule of accounts payable and accrued liabilities Schedule of Lease liability Schedule of income tax benefit Schedule of reconciliation income tax rates Schedule of deferred tax assets and liabilities Schedule of inputs associated with calculating the fair value Schedule of stock option reserve Schedule of share options issued and outstanding Schedule of weighted-average estimated fair value of share options Schedule of weighted average exercise price and the remaining contractual life Schedule of Share options granted and outstanding Schedule of loss and share data used in the basic and diluted EPS calculations Schedule of anti-dilutive effect on loss per share Schedule of compensation payable Schedule of Compensation Schedule of outstanding equity awards [custom:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock] Schedule of liabilities measured at fair value on a recurring basis Schedule of segment reporting Schedule of non-controlling interest Cash Total Current Liabilities Net Loss Income Cash Used In Operating Activities cash, cash equivalents Restricted cash on hand Disclosure of subsidiaries [table] Percentage of outstanding shares Percentage of ownership subsidiary Non-controlling interest Non-controlling interest increased upon conversion Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] Anti-dilutive effect on loss per share Investments Cash restricted for use Prepaid clinical research costs Prepaid insurance Other prepaid expenses Prepaid investor relations Tax deposits Prepaid GPU infrastructure costs Prepaid GPU leases, short-term Other receivables   Total prepaid expenses and other receivables Other assets long term portion Security deposits Disclosure of detailed information about financial instruments [table] stablecoins Disclosure of transactions between related parties [table] Digital asset value as of April 1 Contribution of Stablecoin Proceeds from sale of digital assets Stablecoin used to settle operating costs Stablecoin sold Proceeds from external debt drawdown Purchases of stablecoin Stablecoin value as of March 31 Approximate number of TON Tokens held TON Tokens, fair value (in thousands) Digital assets, fair value (in thousands) Disclosure of intangible assets material to entity [table] Unrealized losses on digital assets recognized in Statement of Operations Digital assets sold Digital asset purchases Receipt of digital assets receivable Realized (loss) gain on sale of digital assets Realized loss on novation of digital assets to investor Revenue received in digital assets Tokens used to settle put rights Digital assets exchanged Digital assets transacted Digital asset value as of March 31 Fiscal 2027 Fiscal 2028 Fiscal 2029 total  Contribution of digital asset and stablecoin receivables Change in fair value of digital assets receivable Receipt of digital asset receivables Stablecoin value as of September 30 Digital assets TON tokens receivable TON tokens receivable shares Tokens are payable Disclosure of detailed information about property, plant and equipment [table] As of March 31, 2025 Fixed asset additions Fixed asset disposals As of March 31, 2026 As of March 31, 2025 Fixed asset depreciation Fixed asset disposals As of March 31, 2026 Property plant equipment carrying amount Balance as of April 1 Initial investment in Compedica Loss from equity method investment Loss on impairment Change in fair value of investment in Compedica Return of investment interest to Compedica Investment in Compedica as of March 31 reimbursement of expenses Loss on impairment Change in fair value on the investment in Compedica Fair value of warrants at issuance exercise price Fair value of warrants shares Fair value of warrants amount Change in fair value of warrant liability, amount Warrants outstanding, shares at ending Warrants outstanding, fair value at ending Warrants outstanding, shares at ending Warrants outstanding, fair value at ending Exercise price Share price Expected life Expected volatility Risk free interest rate Expected dividend Fair value of warrant per share Alp shares and ton correlation factor Share price Remaining term (in years) Expected ALP volatility ALP dividend yield TON token price Locked TON token discount for lack of marketability rate Balance as of April 1 Put right recognition at contract inception Change in fair value of put right liability, net of redemptions Exercise of side letter put right Settlement of DWF Maas Limited put right Put right liability as of March 31 Balance as of April 1 Exercise of side letter put right Settlement of put right liability using digital assets TON payable as of March 31 Treasury Management Agreement description Fair value of stablecoin receivable Fair value of contribution USD1 receivable loss on the exercise Outstanding Contingent Put Options fair value Remeasurement change in fair value Accounts payable Accrued other professional fees Accrued accounting and auditing fees Accrued bonuses and other payroll-related expenses Accrued CRO Accrued legal fees Accrued clinical and R&D services Capital expenditures Other Total accounts payable and accrued liabilities 2027 2028 Total Less: Interest Total lease liability Lease liability - current Lease liability - non-current Commencement Purchase price Purchase equipment payment Master Loan Agreement description Current tax: Current tax on profits for the year Adjustments for current tax of prior periods Total current tax benefit Deferred income tax: Decrease (increase) in deferred tax assets Income tax benefit Loss before income tax Tax using BVI tax rate of 0% Effect of tax rates in other countries Derecognition of deferred tax assets Nondeductible expenses Utilization of losses not previously benefitted Income tax effects related to equity compensation Foreign currency effect and other Income tax in the statement of loss Deferred tax assets: Tax loss Share-based compensation Reserves and accruals Total deferred tax assets Deferred tax asset not recognized Net deferred tax asset U.S. federal net operating losses UK Loss carry forwards deferred tax assets Disclosure of offsetting of financial assets [table] Sale of stock aggregate proceeds Share price Warrants to purchase Purchase price Gross proceeds Dgital assets Ordinary shares issued Number of shares sold net proceeds Treasury stock Aggregate offering ordinary shares ProceedsFromExerciseOfWarrants Net proceeds Pre-funded warrants issued pre-funded warrants outstanding shares Additional shares issued Warrants purchase Fair value of warrants Stock Option Reserve Stock based compensation expense Correction of prior period overstated share-based compensation expense Ending balance Disclosure of defined benefit plans [table] Beginning balance Granted Expired or forfeited Ending balance Exercisable as at end Available for future awards Disclosure of fair value measurement of assets [table] Grant price Expected life Expected dividend as percentage, share options granted Weighted average exercise price Weighted average remaining contractual life (in years) Disclosure of quantitative information about financial instruments that have yet to transition to alternative benchmark rate [table] Expiration Date Exercise Price Share Options Authorized grant option purchase shares Shares issued granted RSU Shares issued Shares issued Shares repurchased into treasury employee payroll taxes Share based compensation expense Share based compensation expense Reversal of share-based compensation Share based compensation expense unvested share options Weighted average shares outstanding, Diluted Loss per share, Basic Loss per share, Diluted Anti-dilutive effect on loss per share service fees Budget costs Unbilled services Forfeited advanced payments Net gain Accounts payable and accrued liabilitie prepaid expenses and other receivables Contractual payments Security deposit Networking equipment cost Deposit Short-term employee benefits (salary, bonus, etc.) Post-employment benefits Other long-term benefits Termination benefits Share-based payment compensation  Total Fee and salary Bonus Transaction closing bonus Securities under option granted Shares ot units Other compensation Total compensation Grant Date Weighted average number of ordinary shares used in calculating diluted earnings per share Number of Securities Underlying Unexercised Options Un Exercisable Exercise Prices Option Expiration Date Number of Share Units of Stock Thet Have Not Vested Market Value Number of Share Units of Stock Thet Have Not Vested sale of stock DecentraNet Financial assets Prepaid expenses and other current assets Financial liabilities Accounts payable and accrued liabilities Warrant liability Lease liability - current and noncurrent Disclosure of financial assets that are either past due or impaired [table] Digital assets at fair value, TON liquid Digital assets at fair value, TON locked Segment revenues Segment expenses Depreciation and amortization expense Segment loss from operations Loss on revaluation of digital assets Loss on revaluation of digital asset receivables Impairment loss - investment in Compedica Loss on revaluation of investment in Compedica Loss on settlement of put right liability Foreign exchange transaction (loss) gain Interest (expense) income, net Gain on forgiveness of loan interest Share of losses from equity method investment Segment loss before benefit for income taxes Income tax benefit Segment net loss Payables and accrued expenses Put right liabilities Current assets Non-controlling interest, at beginning Net (loss) attributable to non-controlling interest Non-controlling interest, at ending Current assets [Default Label] Non-current assets [Default Label] Assets [Default Label] Current liabilities [Default Label] Non-current liabilities [Default Label] Liabilities Treasury shares Equity attributable to owners of parent Equity Equity and liabilities Depreciation and amortisation expense Profit (loss) before tax Tax expense (income) Comprehensive income Profit (loss), attributable to non-controlling interests Comprehensive income, attributable to owners of parent Comprehensive income, attributable to non-controlling interests Number of shares outstanding Increase (decrease) in deferred tax liability (asset) ChangeInFairValueOfWarrantLiability Dividends received Adjustments for decrease (increase) in trade accounts receivable Adjustments for decrease (increase) in prepaid expenses Adjustments for decrease (increase) in other assets Cash flows from (used in) operating activities PurchasesOfDigitalAssets Purchase of property, plant and equipment, classified as investing activities EquipmentDeposit CashPaidForInvestmentInCompedica Cash flows from (used in) investing activities Payments for share issue costs PutRightIssuanceCosts Payments of lease liabilities, classified as financing activities PaymentsOnExternalDebt DeferredFinancingCosts LoanTerminationFee Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Current restricted cash and cash equivalents DescriptionOfAccountingPolicyFoStablecoinExplanatory DescriptionOfAccountingPolicyForDigitalAssetsExplanatory ScheduleOfPutRightLiabilityTableTextBlock ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock ScheduleOfAntiDilutiveEffectTableTextBlock Proportion of ownership interests held by non-controlling interests Property, plant and equipment, revalued assets, at cost AccumulatedDepreciationPropertyPlantAndEquipment FixedAssetDisposals WarrantsLiabilityShares WarrantsLiabilityFairValue Weighted average exercise price of share options outstanding in share-based payment arrangement BalanceOfPutRightLiability BalanceOfTonPayable ExerciseOfSideLetterPutRightPayable SettlementOfPutRightLiabilityUsingDigitalAssets LeaseLiabilityCurrent LeaseLiabilityNoncurrent Net deferred tax assets DeferredTaxAssetNotRecognized NetDeferredTaxAsset SharesPrice PurchasePrice Stock Option Reserve CorrectionOfPriorPeriodOverstatedSharebasedCompensationsExpense NumberOfOutstandingShareOption OptionLifeShareOptionsGranted SharebasedCompensationExpense WeightedAverageSharesOutstandingDiluted LossPerShareBasic LossPerShareDiluted AntidilutiveEffectOnLossPerShare AccountsPayableAndAccruedLiabilities Warrant liability [Default Label] Net foreign exchange gain IncomeTaxBenefit CurrentAsset